Gene expression-based prognostic signatures in lung cancer not ready for clinical use

A review of published articles on gene expression-based prognostic signatures in lung cancer revealed little evidence that any of the signatures are ready for clinical use. Serious problems in the design and analysis of the studies were also found. The review was published online March 16, 2010 in the Journal of the National Cancer Institute.

Read the whole article on Physorg

More from Physorg